Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Kidswell Bio Corporation develops pharmaceuticals for the treatment of rare and intractable diseases in Japan. Its pipeline products include GND-004 for the treatment of ophthalmic disease and oncology; GND-007 for the treatment of immunological disease; and antibodies for oncology. The company pipeline products also include GBS-001, GBS-004, and GBS-010 for oncology; GBS-005 for immunological diseases;...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITD
Target Price
The average target price of 4584.T is 450 and suggests 66% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell